Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!

Treglia G, Giovanella L.

Eur J Nucl Med Mol Imaging. 2019 Nov 21. doi: 10.1007/s00259-019-04563-6. [Epub ahead of print] No abstract available.


Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on 18F-Fluoride PET/CT than on 68Ga-Dotatate PET/CT.

Duarte PS, de Castroneves LA, Sado HN, Sapienza MT, de Oliveira Hoff AAF, Buchpiguel CA.

Nucl Med Mol Imaging. 2018 Aug;52(4):318-323. doi: 10.1007/s13139-018-0527-8. Epub 2018 Jun 4.


Unusual Soft Tissue Uptake of F-18 Sodium Fluoride in Three Patients Undergoing F-18 NaF PET/CT Bone Scans for Prostate Cancer.

Hawkins AS, Howard BA.

Nucl Med Mol Imaging. 2017 Sep;51(3):274-276. doi: 10.1007/s13139-016-0420-2. Epub 2016 May 16.


F-18 fluoride uptake in primary breast cancer.

Sarikaya I, Sharma P, Sarikaya A.

Ann Nucl Med. 2018 Dec;32(10):678-686. doi: 10.1007/s12149-018-1294-4. Epub 2018 Sep 3.


A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.

Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.

J Nucl Med. 2017 Nov;58(11):1778-1785. doi: 10.2967/jnumed.116.189183. Epub 2017 Aug 10.


Comparison of 18F-NaF PET/CT and 18F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma.

Zhang Y, Chen Y, Huang Z, Zhang L, Wan Q, Lei L.

Contrast Media Mol Imaging. 2018 Sep 5;2018:8271313. doi: 10.1155/2018/8271313. eCollection 2018.


Prospective comparison of 18F-NaF PET/CT versus 18F-FDG PET/CT imaging in mandibular extension of head and neck squamous cell carcinoma with dedicated analysis software and validation with surgical specimen. A preliminary study.

Lopez R, Gantet P, Salabert AS, Julian A, Hitzel A, Herbault-Barres B, Fontan C, Alshehri S, Payoux P.

J Craniomaxillofac Surg. 2017 Sep;45(9):1486-1492. doi: 10.1016/j.jcms.2017.06.025. Epub 2017 Jul 8.


Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.

Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J, Cheow HK, Shaw AS, Bird N, Fife K, Heard S, Lomas DJ, Matakidou A, Soloviev D, Eisen T, Gallagher FA.

Ann Oncol. 2015 Oct;26(10):2113-8. doi: 10.1093/annonc/mdv289. Epub 2015 Jul 22.


The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.

Yen RF, Chen CY, Cheng MF, Wu YW, Shiau YC, Wu K, Hong RL, Yu CJ, Wang KL, Yang RS.

Nucl Med Commun. 2010 Jul;31(7):637-45. doi: 10.1097/MNM.0b013e3283399120.


18F-FDG and 18F-NaF PET/CT Findings of a Multiple Myeloma Patient With Thyroid Cartilage Involvement.

Oral A, Yazici B, Ömür Ö, Comert M, Saydam G.

Clin Nucl Med. 2015 Nov;40(11):873-6. doi: 10.1097/RLU.0000000000000908.


Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.

Bastawrous S, Bhargava P, Behnia F, Djang DS, Haseley DR.

Radiographics. 2014 Sep-Oct;34(5):1295-316. doi: 10.1148/rg.345130061. Review.


F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.

Weinberg RL, Morgenstern R, DeLuca A, Chen J, Bokhari S.

J Nucl Cardiol. 2017 Dec;24(6):2015-2018. doi: 10.1007/s12350-016-0525-0. Epub 2016 May 19.


Technical feasibility, radiation dosimetry and clinical use of 18F-sodium fluoride (NaF) in evaluation of metastatic bone disease in pediatric population.

Usmani S, Van den Wyngaert T, Ahmed N, Marafi F, Esmail A, Al Kandari F, Al Nuaimi M, Gnanasegaran G.

Ann Nucl Med. 2018 Nov;32(9):594-601. doi: 10.1007/s12149-018-1279-3. Epub 2018 Jul 17.


The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.

Kulshrestha RK, Vinjamuri S, England A, Nightingale J, Hogg P.

J Nucl Med Technol. 2016 Dec;44(4):217-222. Epub 2016 Sep 15. Review.


Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by 18F-sodium fluoride PET/CT.

Ishiwata Y, Kaneta T, Nawata S, Hino-Shishikura A, Yoshida K, Inoue T.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1529-1537. doi: 10.1007/s00259-017-3680-x. Epub 2017 Mar 27.


Correlation of fluorine 18-labeled sodium fluoride uptake and arterial calcification on whole-body PET/CT in cancer patients.

Dai D, Chuang HH, Macapinlac HA, Li T, Pan T.

Nucl Med Commun. 2019 Jun;40(6):604-610. doi: 10.1097/MNM.0000000000000986.


Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT.

Usmani S, Marafi F, Ahmed N, Esmail A, Al Kandari F, Van den Wyngaert T.

Clin Nucl Med. 2017 Nov;42(11):829-836. doi: 10.1097/RLU.0000000000001823.


(18)F-sodium fluoride PET/CT for the in vivo visualization of Mönckeberg's sclerosis in a diabetic patient.

Quirce R, Martínez-Rodríguez I, Banzo I, de Arcocha-Torres M, Jiménez-Bonilla JF, Martínez-Amador N, Ibáñez-Bravo S, Ramos L, Amado JA, Carril JM.

Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):314-6. doi: 10.1016/j.remn.2015.04.004. Epub 2015 May 29.


Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions.

Capitanio S, Bongioanni F, Piccardo A, Campus C, Gonella R, Tixi L, Naseri M, Pennone M, Altrinetti V, Buschiazzo A, Bossert I, Fiz F, Bruno A, DeCensi A, Sambuceti G, Morbelli S.

World J Radiol. 2016 Feb 28;8(2):200-9. doi: 10.4329/wjr.v8.i2.200.

Supplemental Content

Support Center